Executive Director, Clinical Development Program Lead (Neuropsychiatry) at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, NeuropsychiatryIndustries

Requirements

Advanced degree in a relevant scientific field (implied by role seniority and responsibilities in clinical development)
Extensive experience in clinical development, including strategy, design, execution, and interpretation of clinical trials
Proven track record in drug development across phases, from phase I expansion through registrational execution and lifecycle management
Experience in neuropsychiatry or related therapeutic area (specific to role focus)
Leadership experience managing large teams (up to 50 individuals, direct and indirect reports)
Expertise in regulatory filings, benefit-risk assessments, and translational elements
Familiarity with R&D, GDD, GT4/5, and POC transitions

Responsibilities

Create and communicate a vision for designing, conducting, and executing innovative clinical development plans
Set the clinical development strategy for assets or indications, including above disease/indication strategy work
Directly supervise multiple Clinical Development Leads (who supervise Clinical Trial Physicians)
Supervise the development, monitoring, analysis, and interpretation of clinical trials
Hold accountability for the clinical components of regulatory filings
Contribute to overall strategy for specific diseases/indications while maintaining a franchise portfolio view
Provide strategic insights into clinical development plans
Lead search and evaluation activities for business development due diligence and advise strategic transactions group
Serve as a key member of the Therapeutic Area Clinical Development Leadership Team, chair forums as required, chair departmental Staff Meetings, and represent governance meetings
Build a franchise reputation to attract innovators
Lead and develop a group of Clinical Development professionals (up to 50 individuals) focused on a specific disease area/indication, ensuring scientific and technical excellence
Support GT4/5 and POC transitions with insights into biology, translational elements, and benefit-risk assessments
Supervise development of differentiated Clinical Development Physicians for multiple transition assets
Support across-portfolio activities, including Protocol Review Committee, Business Development, and Quality/Compliance leadership
Report directly to the Head of Clinical Development, deputize as required, and serve as a core member of the executive leadership team

Skills

Clinical Development

Drug Development

Clinical Trials

Program Leadership

Disease Strategy

Translational Medicine

Benefit Risk Assessment

R&D

Team Supervision

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free